Crossmark

Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness

Crossref DOI link: https://doi.org/10.1186/S13014-019-1432-8

Published Online: 2019-12-30

Published Print: 2019-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

Authors

Tseng, Yolanda D. http://orcid.org/0000-0002-4070-346X
Maes, Shadonna M.

Kicska, Gregory

Sponsellor, Patricia

Traneus, Erik

Wong, Tony

Stewart, Robert D.

Saini, Jatinder
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2019-12-30
More Information

Article History

Received: 30 May 2019

Accepted: 27 November 2019

First Online: 30 December 2019

Ethics approval and consent to participate

: We obtained approval from the University of Washington Institutional Review Board.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below